The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 28, 2025

Filed:

Mar. 22, 2022
Applicants:

Everest Medical Innovation Gmbh, Baar, CH;

Regents of the University of Minnesota, Minneapolis, MN (US);

Inventors:

Franz Schmidlin, Geneva, CH;

John Bischof, St. Paul, MN (US);

Paul A. Iaizzo, White Bear Lake, MN (US);

Qi Shao, Plymouth, MN (US);

Pegah Ranjbartehrani, Falcon Heights, MN (US);

David A. Ramirez, St. Paul, MN (US);

Alexandre Porcello, Belmont-sur Yverdon, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/02 (2006.01); A61L 31/02 (2006.01); A61L 31/04 (2006.01); A61L 31/16 (2006.01); A61M 5/32 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61L 31/16 (2013.01); A61B 18/02 (2013.01); A61L 31/028 (2013.01); A61L 31/042 (2013.01); A61M 5/3294 (2013.01); A61B 2018/00101 (2013.01); A61B 2018/00547 (2013.01); A61L 2300/216 (2013.01); A61L 2300/232 (2013.01); A61L 2400/06 (2013.01);
Abstract

A surgical kit for providing a cryoprotective composition configured to be applied during cryotreatment of a patient includes: a first container containing a predetermined amount or volume of a biodegradable and/or bioerodible fluid agent; and a second container containing a predetermined amount or volume of a non-toxic cryoprotectant agent. The predetermined amount or volume of the of biodegradable and/or bioerodible fluid agent and the predetermined amount or volume of a non-toxic cryoprotectant agent are configured to be mixed together to form the cryoprotective composition in which a therapeutically effective amount of the cryoprotective composition deposited in a body space of the patient in proximity to the cryotreatment remains within at least a portion of the body space for a duration of the cryotreatment and at least a portion of a body tissue proximate to the body space is viable after the cryotreatment.


Find Patent Forward Citations

Loading…